Departments of Neurology and.
J Neurosurg. 2014 May;120(5):1188-92. doi: 10.3171/2014.1.JNS131619. Epub 2014 Mar 14.
The aim of this study was to determine the prospective hemorrhage rate in a group of retrospectively identified patients in whom symptoms had an unclear relationship to an intracerebral cavernous malformation (ICM) or the malformation itself was an incidental finding.
Patients with incidentally discovered ICMs diagnosed between 1989 and 1999 were identified from a previously published cohort. Those with ICMs having an unclear relationship with existing symptoms were also eligible for analysis. Updated clinical and radiographic data pertaining to symptomatic intracerebral hemorrhage related to the ICM or new seizures were obtained through medical chart review and mail survey. In select patients, phone calls were made and death certificates were obtained when possible. The prospective hemorrhage rate was calculated as the number of prospective hemorrhages divided by the number of patient-years of follow-up.
There were 1311 patient-years of follow-up among the 107 patients (49.5% male; mean age at diagnosis 52 years) eligible for this study. Forty-four patients died in the follow-up period, and the cause of death could be determined in 34 (77%). Two patients had a prospective hemorrhage, which was definitively related to the ICM in only one. Thus, the definitive prospective bleed rate was 0.08% per patient-year. No new seizures developed in any of the patients during the follow-up period.
The risk of prospective hemorrhage in patients presenting asymptomatically with ICM is very low. This information can be useful in managing such patients and may be most applicable to those with a single ICM.
本研究旨在确定一组回顾性确定的患者中,有症状的患者与颅内海绵状血管畸形(ICM)之间的关系不明确或畸形本身是偶然发现的情况下,前瞻性出血率。
从先前发表的队列中确定了 1989 年至 1999 年诊断出的偶发性 ICM 患者。有症状的 ICM 与现有症状之间关系不明确的患者也有资格进行分析。通过病历审查和邮件调查获得与 ICM 相关的症状性颅内出血或新发作的更新临床和放射学数据。在选择的患者中,尽可能通过电话联系并获取死亡证明。前瞻性出血率计算为前瞻性出血数除以患者随访年数。
在符合本研究条件的 107 名患者(49.5%为男性;诊断时的平均年龄为 52 岁)中,有 1311 患者年的随访。在随访期间有 44 名患者死亡,其中 34 名(77%)的死因可以确定。2 名患者发生了前瞻性出血,其中只有 1 例明确与 ICM 相关。因此,确定的前瞻性出血率为每年每患者 0.08%。在随访期间,没有患者发生新的癫痫发作。
无症状表现的 ICM 患者发生前瞻性出血的风险非常低。这些信息可用于管理此类患者,最适用于单个 ICM 的患者。